Duncker Streett & Co. Inc. Acquires 1,220 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Duncker Streett & Co. Inc. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 13,531 shares of the healthcare conglomerate’s stock after purchasing an additional 1,220 shares during the period. UnitedHealth Group comprises about 1.5% of Duncker Streett & Co. Inc.’s investment portfolio, making the stock its 13th biggest position. Duncker Streett & Co. Inc.’s holdings in UnitedHealth Group were worth $7,124,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in UNH. Wellington Management Group LLP raised its stake in shares of UnitedHealth Group by 2.1% during the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after buying an additional 527,526 shares during the last quarter. Morgan Stanley raised its stake in shares of UnitedHealth Group by 13.8% during the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate’s stock worth $8,289,386,000 after buying an additional 1,893,192 shares during the last quarter. Moneta Group Investment Advisors LLC raised its stake in shares of UnitedHealth Group by 100,076.4% during the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after buying an additional 11,812,017 shares during the last quarter. Alliancebernstein L.P. increased its stake in UnitedHealth Group by 3.5% in the second quarter. Alliancebernstein L.P. now owns 11,749,819 shares of the healthcare conglomerate’s stock valued at $5,647,433,000 after purchasing an additional 399,739 shares in the last quarter. Finally, Norges Bank bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $5,210,004,000. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Trading Up 5.2 %

NYSE:UNH traded up $23.26 during mid-day trading on Wednesday, hitting $468.89. 11,816,517 shares of the company’s stock were exchanged, compared to its average volume of 4,248,641. The firm has a market capitalization of $432.28 billion, a P/E ratio of 19.68, a PEG ratio of 1.22 and a beta of 0.54. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. The company has a 50 day simple moving average of $490.31 and a 200-day simple moving average of $515.63.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.54 by $0.37. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.26 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.60%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.54%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Stephens restated an “overweight” rating and set a $605.00 target price on shares of UnitedHealth Group in a report on Thursday, February 8th. Oppenheimer reiterated an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Finally, Bank of America reissued a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Three analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $573.80.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.